Literature DB >> 14719465

Total hip arthroplasty in patients younger than 30 years of age.

Israel Dudkiewicz1, Moshe Salai, Amnon Israeli, Yehuda Amit, Aharon Chechick.   

Abstract

BACKGROUND: Previously reported results of total hip arthroplasty in patients under the age of 30 indicate a high complication rate and questionable durability.
OBJECTIVES: To estimate the results of THA in extremely young patients.
METHODS: We report the results of 69 THA procedures in 56 patients who were under the age of 30 at the time of surgery (mean age 23.23 +/- 4.31 years) and were followed postoperatively for 2-23 years (mean 7.4 +/- 3.79 years).
RESULTS: Loosening of the cup (11/69) and early traumatic dislocation (5/69) accounted for the majority of complications.
CONCLUSION: The final average Harris hip scores of 90.59 +/- 9.36 in these patients indicated that THA is a successful and durable treatment modality for young patients with disabling diseases affecting the hip joint. However, due to the likelihood of complications it should be used with caution in this patient group. Efforts should be made to diminish the complication rate.

Entities:  

Mesh:

Year:  2003        PMID: 14719465

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  12 in total

1.  Survivorship of hip and knee implants in pediatric and young adult populations: analysis of registry and published data.

Authors:  Art Sedrakyan; Lucas Romero; Stephen Graves; David Davidson; Richard de Steiger; Peter Lewis; Michael Solomon; Robyn Vial; Michelle Lorimer
Journal:  J Bone Joint Surg Am       Date:  2014-12-17       Impact factor: 5.284

Review 2.  Has total hip arthroplasty in patients 30 years or younger improved? A systematic review.

Authors:  Muyibat A Adelani; James A Keeney; Allison Palisch; Susan A Fowler; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2013-04-06       Impact factor: 4.176

3.  Reconstruction with tibial lengthening for limb length discrepancy in Crowe Type IV developmental dysplasia of hip in adulthood.

Authors:  Tang Liu; Xiangsheng Zhang; Zhihong Li; Wen Zeng
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-02-10

4.  Risk factors for revision of hip arthroplasties in patients younger than 30 years.

Authors:  Julien Girard; Christophe Glorion; François Bonnomet; Damien Fron; Henri Migaud
Journal:  Clin Orthop Relat Res       Date:  2010-11-18       Impact factor: 4.176

5.  Function and fixation of total hip arthroplasty in patients 25 years of age or younger.

Authors:  John C Clohisy; Jeremy M Oryhon; Thorsten M Seyler; Christopher W Wells; Steve S Liu; John J Callaghan; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

Review 6.  Evolution of total hip arthroplasty in patients younger than 30 years of age: A systematic review and meta-analysis.

Authors:  Andrew Konopitski; Chielozor Okafor; Brendan Smith; Keith Baldwin; Neil P Sheth
Journal:  Arch Orthop Trauma Surg       Date:  2022-02-07       Impact factor: 3.067

7.  Alumina-on-alumina hip arthroplasty in patients younger than 30 years old.

Authors:  R Nizard; D Pourreyron; A Raould; D Hannouche; L Sedel
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

8.  Hip resurfacing in patients under thirty years old: an attractive option for young and active patients.

Authors:  Nicolas Krantz; Bruno Miletic; Henri Migaud; Julien Girard
Journal:  Int Orthop       Date:  2012-05-11       Impact factor: 3.075

9.  Cemented hip designs are a reasonable option in young patients.

Authors:  Vincent Busch; Rik Klarenbeek; Tom Slooff; B Willem Schreurs; Jean Gardeniers
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

10.  Mean 5-year clinical and radiographic outcomes of cementless total hip arthroplasty in patients under the age of 30.

Authors:  Jeremy M Gililland; Lucas A Anderson; Jill Erickson; Christopher E Pelt; Christopher L Peters
Journal:  Biomed Res Int       Date:  2013-06-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.